Hostname: page-component-84b7d79bbc-4hvwz Total loading time: 0 Render date: 2024-07-29T11:33:59.184Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of oestradiol and vitamin B6 on tryptophan metabolism in the rat: implications for the interpretation of the tryptophan load test for vitamin B6 nutritional status

Published online by Cambridge University Press:  09 March 2007

David A. Bender
David A. Bender
Affiliation:
Courtauld Institute of Biochemistry, The Middlesex Hospital Medical School, London W1P 7PN
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

1. The effects of the administration of oestradiol and vitamin B6 on tryptophan metabolism in the rat have been assessed by measurement of the release of 14CO2 from [14C]tryptophan, in vivo, in order to determine whether, and to what extent, the abnormalities of tryptophan metabolism that are associated with oestrogen administration can be attributed to drug-induced vitamin B6 deficiency or depletion. Two positional isomers of [14C]tryptophan have been used; [ring-2-14C]tryptophan as an index of the activity of tryptophan oxygenase (L-tryptophan: oxygen oxidoreductase (decyclizing), EC 1.13.11.11) and [methylene-14C]trytophan as an index of the activity of kynureninase (L-kynurenine hydrolase, EC 3.7.1.3).

2. The administration of 500 μg oestradiol/kg body-weight led to a reduction in the release of 14CO2 from both positional isomers of tryptophan, suggesting that the activities of both tryptophan oxygenase and kynureninase are reduced following oestrogen treatment. The kinetics of the release of 14CO2 from [methylene-14C]tryptophan after the administration of oestradiol were compatible with competitive inhibition of kynureninase by oestradiol or a metabolite.

3. The administration of 10 mg pyridoxine hydrochloride/kg body-weight also reduced the production of 14CO2 from both positional isomers of 14C]tryptophan, suggesting some toxicity of such a high dose of the vitamin.

4. In animals which had received the supplementary dose of vitamin B6, the administration of oestradiol led to further reduction in the production of 14CO2 from [ring-2-14C]tryptophan, suggesting a further reduction in the activity of tryptophan oxygenase, and an increase in the production of 14CO2 from [methylen-14C]tryptophan, but with a delay in the peak of production.

5. These results confirm that there is no induction of tryptophan oxygenase by oestradiol, but rather reduced activity of the enzyme after the administration of a relatively high dose of the hormone. They also confirm that the inhibition of kynureninase by oestrogen metabolites that has been reported previously in partially-purified enzyme preparations also occurs in vivo.

6. It is suggested that the abnormal results of the tryptophan load test that have been reported in women receiving oestrogens, and which have been interpreted as indicating some extent of drug-induced vitamin B6 deficiency, can be accounted for by the inhibition of tryptophan metabolism by oestrogens or their metabolites. Therefore it seems likely that the practice of administering supplements of vitamin B6 to women receiving oestrogens may not be appropriate, and indeed may exacerbate the changes in tryptophan metabolism that result from the administration of oestrogens. The tryptophan load test would appear to be unreliable as an index of vitamin B6 nutritional status in women receiving oestrogens.

Type
Papers of direct relevance to Clinical and Human Nutrition
Information
British Journal of Nutrition , Volume 50 , Issue 1 , July 1983 , pp. 33 - 42
Copyright
Copyright © The Nutrition Society 1983

References

REFERENCES

Aylward, M. (1976). In The Management of the Menopause and Post-menopausal Years, pp. 135–147 [Campbell, S., editor]. Lancaster: MTP Press.CrossRefGoogle Scholar
Bender, D. A. (1980 a). Biochemical Pharmacology 29, 707–712.CrossRefGoogle Scholar
Bender, D. A. (1980 b). Biochemical Pharmacology 29, 2099–2104.CrossRefGoogle Scholar
Bender, D. A., Laing, A. E., Vale, J. A., Papadaki, L. & Pugh, M. (1983). Biochemical Pharmacology 32, 843–848.CrossRefGoogle Scholar
Bender, D. A., Tagoe, C. E. & Vale, J. A. (1982). British Journal of Nutrition 47, 609–614.CrossRefGoogle Scholar
Bender, D. A. & Wynick, D. (1981). British Journal of Nutrition 45, 269–275.CrossRefGoogle Scholar
Brown, R. R., Rose, D. P., Leklem, J. E., Linkswiler, H. & Anand, R. (1975). American Journal of Clinical Nutrition 28, 10–19.CrossRefGoogle Scholar
Carpenter, K. J. & Kodicek, E. (1950). Biochemical Journal 46, 421–426.CrossRefGoogle Scholar
Coon, W. W. & Nagler, E. (1969). Annals of the New York Academy of Sciences 166, 30–43.CrossRefGoogle Scholar
Coursin, D. B. (1964). American Journal of Clinical Nutrition 14, 56–61.CrossRefGoogle Scholar
Holman, W. I. M. (1954). Biochemical Journal 56, 513–520.CrossRefGoogle Scholar
Holman, W. I. M. & Wiegand, C. (1948). Biochemical Journal 43, 423–426.CrossRefGoogle Scholar
Joseph, M. H. & Risby, D. (1975). Clinica Chimica Acta 63, 197–204.CrossRefGoogle Scholar
Knox, W. E. (1953). Biochemical Journal 53, 385–397.CrossRefGoogle Scholar
Leklem, J. E., Brown, R. R., Rose, D. P. & Linkswiler, H. (1975). American Journal of Clinical Nutrition 28, 535–541.CrossRefGoogle Scholar
Leonard, B. E. & Hamburger, A. D. (1974). Biochemical Society Transactions 2, 1351–1355.CrossRefGoogle Scholar
Luhby, A. L., Brin, M., Gordon, M., David, P., Murphy, M. & Spiegel, H. (1971). American Journal of Clinical Nutrition 24, 684–693.CrossRefGoogle Scholar
Patnaik, S. K. & Sarangai, S. (1980). Journal of Biochemistry (Tokyo) 87, 1249–1252.Google Scholar
Price, J. M. (1954). Journal of Biological Chemistry 211, 117–124.CrossRefGoogle Scholar
Price, J. M., Brown, R. R. & Yess, N. (1965). Advances in Metabolic Disorders 2, 159–225.CrossRefGoogle Scholar
Rose, D. P. & Braidman, I. (1971). American Journal of Clinical Nutrition 24, 673–683.CrossRefGoogle Scholar
Rose, D. P., Strong, R., Adams, P. W. & Harding, P. E. (1972). Clinical Science 42, 465–477.CrossRefGoogle Scholar
Satoh, K. & Price, J. M. (1958). Journal of Biological Chemistry 230, 781–789.CrossRefGoogle Scholar
Serdaru, M., Escourelle, R., de Baecque, C., Hauw, J. J., Lambolez, T. & Constans, P. (1981). Nouvelle Presse Medicale, 3705–3707.Google Scholar
Watanabe, M., Watanabe, Y. & Okada, M. (1970). Clinica Chimica Acta 27, 461–466.CrossRefGoogle Scholar
Wein, E. M. (1978). American Journal of Clinical Nutrition 31, 1392–1396.CrossRefGoogle Scholar
Young, S. N., St. Arnaud-McKenzie, D. & Sourkes, T. L. (1978). Biochemical Pharmacology 27, 763–767.CrossRefGoogle Scholar